Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-analysis of Tracer Uptake.
Christenhusz A, Mirzaei N, Karakatsanis A, Eriksson S, Wärnberg F, Olofsson Bagge R, van der Palen J, Simanowski J, Salamzadeh S, Ten Haken B, Dassen AE, Alic L. Christenhusz A, et al. Among authors: olofsson bagge r. Ann Surg Oncol. 2024 Dec 17. doi: 10.1245/s10434-024-16626-6. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39690385
Development of an optimized MRI protocol for a rapid preoperative identification of sentinel lymph nodes using superparamagnetic iron oxide - The Gothenburg fast acquisition sentinel lymph node tracking magnetic resonance imaging protocol (GO-FAST-MRI).
Zaar P, Mirzaei N, Jalnefjord O, de Coursey E, Johansson I, Wärnberg F, Leonhardt H, Olofsson Bagge R. Zaar P, et al. Among authors: olofsson bagge r. Eur J Surg Oncol. 2025 Jan;51(1):109362. doi: 10.1016/j.ejso.2024.109362. Epub 2024 Nov 9. Eur J Surg Oncol. 2025. PMID: 39637687
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases.
DePalo DK, Dugan MM, Naqvi SMH, Ollila DW, Hieken TJ, Block MS, van Houdt WJ, Wouters MWJM, Reijers SJM, Asher N, Broman KK, Duncan Z, Anderson M, Gyorki DE, Snow H, Held J, Farma JM, Vetto JT, Hui JYC, Kolbow M, Saw RPM, Lo SN, Long GV, Thompson JF, Kim Y, Karapetyan L, Ny L, van Akkooi ACJ, Olofsson Bagge R, Zager JS. DePalo DK, et al. Among authors: olofsson bagge r. Cancer. 2025 Jan 1;131(1):e35636. doi: 10.1002/cncr.35636. Epub 2024 Nov 10. Cancer. 2025. PMID: 39522025
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer.
Skarping I, Bendahl PO, Szulkin R, Alkner S, Andersson Y, Bergkvist L, Christiansen P, Filtenborg Tvedskov T, Frisell J, Gentilini OD, Kontos M, Kühn T, Lundstedt D, Vrou Offersen B, Olofsson Bagge R, Reimer T, Sund M, Rydén L, de Boniface J. Skarping I, et al. Among authors: olofsson bagge r. JAMA Surg. 2024 Dec 1;159(12):1393-1403. doi: 10.1001/jamasurg.2024.3944. JAMA Surg. 2024. PMID: 39320882 Free PMC article. Clinical Trial.
Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment.
Holmberg CJ, Zijlker LP, Katsarelias D, Huibers AE, Wouters MWJM, Schrage Y, Reijers SJM, van Thienen JV, Grünhagen DJ, Martner A, Nilsson JA, van Akkooi ACJ, Ny L, van Houdt WJ, Olofsson Bagge R. Holmberg CJ, et al. Among authors: olofsson bagge r. Eur J Surg Oncol. 2024 Dec;50(12):108653. doi: 10.1016/j.ejso.2024.108653. Epub 2024 Sep 7. Eur J Surg Oncol. 2024. PMID: 39266404 No abstract available.
Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial.
de Boniface J, Appelgren M, Szulkin R, Alkner S, Andersson Y, Bergkvist L, Frisell J, Gentilini OD, Kontos M, Kühn T, Lundstedt D, Offersen BV, Olofsson Bagge R, Reimer T, Sund M, Christiansen P, Rydén L, Filtenborg Tvedskov T; SENOMAC Trialists’ Group. de Boniface J, et al. Among authors: olofsson bagge r. Lancet Oncol. 2024 Sep;25(9):1222-1230. doi: 10.1016/S1470-2045(24)00350-4. Epub 2024 Aug 6. Lancet Oncol. 2024. PMID: 39121881 Clinical Trial.
A phase Ib randomized multicenter trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab for uveal melanoma metastases (SCANDIUM II trial).
Olofsson Bagge R, Nelson A, Shafazand A, Cahlin C, Carneiro A, Helgadottir H, Levin M, Rizell M, Ullenhag G, Wirén S, Lindnér P, Nilsson JA, Ny L. Olofsson Bagge R, et al. ESMO Open. 2024 Jul;9(7):103623. doi: 10.1016/j.esmoop.2024.103623. Epub 2024 Jul 2. ESMO Open. 2024. PMID: 38959698 Free PMC article. Clinical Trial.
Understanding quality of life issues in patients with advanced melanoma: Phase 1 and 2 in the development of the EORTC advanced melanoma module.
Egeler MD, van Leeuwen M, Lai-Kwon J, Eriksson H, Bartula I, Elashwah S, Fox L, Van Hemelrijck M, Jefford M, Lijnsvelt J, Bagge AL, Morag O, Ny L, Olofsson Bagge R, Rogiers A, Saw RPM, Serpentini S, Iannopollo L, Thompson J, Stiller HT, Vanlaer N, van Akkooi ACJ, van de Poll-Franse LV; EORTC Quality of Life Group. Egeler MD, et al. Among authors: olofsson bagge r. Eur J Cancer. 2024 Aug;207:114176. doi: 10.1016/j.ejca.2024.114176. Epub 2024 Jun 12. Eur J Cancer. 2024. PMID: 38875843
Quality assessment of radiotherapy in the prospective randomized SENOMAC trial.
Alkner S, Wieslander E, Lundstedt D, Berg M, Kristensen I, Andersson Y, Bergkvist L, Frisell J, Olofsson Bagge R, Sund M, Christiansen P, Davide Gentilini O, Kontos M, Kühn T, Reimer T, Rydén L, Filtenborg Tvedskov T, Vrou Offersen B, Dahl Nissen H, de Boniface J; SENOMAC Trialists’ Group. Alkner S, et al. Among authors: olofsson bagge r. Radiother Oncol. 2024 Aug;197:110372. doi: 10.1016/j.radonc.2024.110372. Epub 2024 Jun 10. Radiother Oncol. 2024. PMID: 38866204 Free article. Clinical Trial.
132 results